OxGEn ImPort


NEB png
New Project (5).png
altona png
idt png
mettler toledo png
eufins png


Today’s Efforts Against Tomorrow’s Infectious Diseases

Gaining a better understanding of infectious diseases, including their characterization, evolution and transmission, continues to be a priority, both from an R&D standpoint and as a public health issue.


New England Biolabs® Launches LyoPrime Luna™ RT-qPCR Master Mix

IPSWICH, Mass., (February 09, 2022) — Today, New England Biolabs (NEB®) announced the release of its first lyophilized product manufactured by Fluorogenics


NEB releases next generation HiScribe™ in vitro transcription kit

IPSWICH, MA (November 8th, 2021) – New England Biolabs (NEB®) announced today that they have released a kit for the generation of in vitro transcribed synthetic mRNA G.


1163035_873099_ans_5dd599d0803c4dcea4f075ae13bdec29 (1).png
"Work with us at the edge of impossible "

― OxGEn